The SLIDEVIEW™ DX Combines Microscope-Quality Images with Fast Slide Scanning for Efficient Digital Pathology

Helps Pathologists Make Diagnoses^* Quickly

WALTHAM, Mass., (June 13, 2023)—The new Evident SLIDEVIEW™ DX VS-M1 whole slide imaging system is a digital pathology solution that delivers high-quality slide images at high speed, helping pathologists make diagnoses^* quickly and efficiently. Built with renowned optics and advanced digital technology, the SLIDEVIEW DX slide scanner is a complete digital pathology solution.

Supports Efficient Diagnoses

The SLIDEVIEW DX scanner provides microscope-quality images onscreen. The system’s objective uses the same leading-edge technology as our award-winning X Line™ series to capture images with exceptional flatness and a high resolution. The result is seamlessly stitched whole slide images that are fully in focus.

Correctly displaying the colors from pathology stains is critical, so the SLIDEVIEW DX scanner uses our True Color high color rendering LED light source for precise color reproduction, and images are displayed on a medical-grade display with automatic color calibration.

The system’s image management system was designed in collaboration with pathologists so that the layout and functionality will be easy for pathologists to learn. A virtual slide tray mimics handling a physical slide on a holder while enabling the pathologist to take measurements and make annotations on the digital slides. For consultation, the scanner’s collaboration tools make it easy to securely share slide images with other pathologists or experts.

Built for Busy Labs

The SLIDEVIEW DX system’s more than 80 slides per hour scan speed and real-time autofocus make it easy to quickly scan many slides. Users can load their slides into the system’s rack and easily place them in the scanner. The controls are clearly laid out on a large touch screen, which is designed to be used while standing. With a few clicks, the user can start the run and walk away. When the scan is complete, the images can be viewed on the same large touch screen and sent directly to the pathologist with the push of a button.

Easy to Onboard and Manage

The system’s software easily integrates with existing LIS systems and supports various healthcare network protocols, like HL-7. The system has HIPAA and NIST data security features, encryption, and central account management. IT technicians can use the system’s central account manager to remotely view scanner system faults, errors and download reports.

For more information about the SLIDEVIEW DX digital pathology solution, visit EvidentScientific.com.

^*In Europe, SLIDEVIEW DX VS-M1 is regulatory compliant (under the name VS-M1) for IVDR (EU)  for in vitro diagnostic use.

• In Singapore, SLIDEVIEW DX VS-M1 is listed (under the name of VS-M1) as a Class A medical device in HSA Class A SMDR.
• In Australia, SLIDEVIEW DX VS-M1 is included (under the name VS-M1) in the ARTG as a Class 1 IVD medical device.
• In New Zealand, SLIDEVIEW DX VS-M1 is regulatory compliant (under the name VS-M1) for the Medicines Act of 1981 (NZ).
• This product is sold under the name SLIDEVIEW VS-M1R in the U.S. as a research use only product and as SLIDEVIEW VS-M1J in Japan notified (under the name VS-M1-IVD1) as a Class I medical device.
• Product currently not available in regions not specified.

About EVIDENT

At Evident, we are guided by the scientific spirit—innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.

Evident Life Science empowers scientists and researchers through collaboration and cutting-edge life science solutions. Dedicated to meeting the challenges and supporting the evolving needs of its customers, Evident Life Science advances a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications as well as for research and education.

For more information, visit EvidentScientific.com.

Media Contact:
Hilary Banda
(781) 419-3624
Hilary.Banda@olympus.com

^*The contents in this press release including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.

^*Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this press release is not intended for advertising or medical advice.

^*Evident Corporation assumes no responsibility for any damage resulting from the use of this material.

^*SLIDEVIEW and X Line are trademarks of Evident Corporation or its subsidiaries.